ALKS vs JLL · P/E 14, rev $1.56B vs P/E 23, rev $23.43B
Alkermes Plc (ALKS) versus Jones Lang LaSalle Incorporated (JLL) — a side-by-side from cached financials, not a winner call.
Alkermes Plc (ALKS) is a drug manufacturers - specialty & generic company listed on US.
Jones Lang LaSalle Incorporated (JLL) is a real estate services company listed on US.
Latest reported ALKS revenue for 2024-12-31 was $1.56B. Net income was $367.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. ALKS currently screens at market cap $4.78B and trailing P/E 13.8.
Latest reported JLL revenue for 2024-12-31 was $23.43B. Net income was $546.8M. Revenue was up 12.9% from 2023-12-31 to 2024-12-31. JLL currently screens at market cap $12.12B and trailing P/E 23.0.
ALKS currently screens at market cap $4.78B and trailing P/E 13.8. JLL currently screens at market cap $12.12B and trailing P/E 23.0.
Not investment advice. Open the ALKS and JLL stock pages for the full models.
Not investment advice.